FDA Fast Track Approval Consulting

Our FDA Fast Track Approval Consulting helps sponsors of high‑need neuro‑therapeutics decide if Fast Track is realistic and how to approach it in a way regulators can trust. We draw on direct experience supporting a disruptive brain tumor device from registry data to FDA approval.

During a Fast Track Eligibility Assessment, we review your indication, mechanism, early data, and target population to judge alignment with serious, unmet medical need criteria. We then outline a clear path: evidence gaps to close, real‑world data options, and how your program might fit into existing neurological standards of care.

If you proceed, we support strategy and submission planning-always mindful that the patients behind the application are often desperate for options that do more than manage symptoms. Our role is to connect scientific ambition with regulatory reality so promising brain therapies reach those patients as quickly and safely as possible.